Crystals "peed" by snakes could hold the key to treating kidney stones and gout in humans, say scientists. Researchers investigated the solid urine of more than 20 reptile species and found spheres of ...

Reptiles produce crystal "pee," which, in humans, would cause gout or kidney stones. But this seems to be working out great ...

Announced on October 11, the launch transforms the former Baxter Kidney Care segment into an independent entity in Vietnam.

Objective Glomerular immune complex deposition plays a central role in lupus nephritis (LN), but the prognostic relevance of individual immunoglobulin components remains unclear. This study aimed to ...

This is read by an automated voice. Please report any issues or inconsistencies here. OpenAI has reached a new tentative agreement with Microsoft and said its nonprofit, which technically controls its ...

Adding the novel medication baxdrostat to standard care may help manage high blood pressure and delay the progression of kidney disease in people with chronic kidney disease and uncontrolled high ...

“I believe that we’ll have between 12 and 18 Democrats at least open to voting for market structure,” Scott said on stage at the SALT conference in Jackson Hole, Wyoming on Tuesday. “The forces ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

INDIANAPOLIS, Ind. (Ivanhoe Newswire) - Kidney stones are common in the United States. One in 10 people will develop one at some point in their life. Once rare in children, doctors say cases are ...

Kidney cancer affects tens-of-thousands every year, but research and care advances are improving survival chances and quality of life for patients. Kidney cancer occurs more frequently than many ...

Editor’s note: “Behind the News” is the product of Sun staff assisted by the Sun’s AI lab, which includes a variety of tools such as Anthropic’s Claude, Perplexity AI, Google Gemini and ChatGPT.

Pegcetacoplan is the first FDA-approved treatment for C3G and primary IC-MPGN, targeting excessive C3 complement activation. The phase 3 VALIANT trial showed a 68% reduction in UPCR and stabilization ...